OBJECTIVES: Type 2 diabetes and the consumption of saturated fatty acids (FAs) are on the rise among Alaska Inuits. This analysis, based on a cross-sectional study, explores the possible associations of saturated FA content in red blood cells (RBCs) and parameters of glucose metabolism in a sample of Alaska Natives. STUDY DESIGN AND METHODS: The sample included 343 women and 282 men aged 35-74. Statistical analyses explored the associations of selected RBC (myristic, palmitic and stearic acids) FAs with fasting glucose (plasma), fasting insulin (plasma), 2h glucose (2-hour glucose tolerance test), 2h insulin and homeostasis model assessment (HOMA) index. The models included sex and glucose metabolism status as fixed factors and age, body mass index (BMI), waist circumference, physical activity (METS) and FA content in RBCs as covariates. Measures of insulin, glucose and HOMA index were used as dependent variables. RESULTS: Myristic acid was positively associated with fasting insulin (β=0.47, p<0.001), 2h insulin (β=0.53, p=0.02) and HOMA index (β=0.455, p<0.001). Palmitic acid was associated with 2h glucose (β=2.3×10(-2), p<0.001) and 2h insulin (β=5.6×10(-2), p=0.002) and stearic acid was associated with fasting glucose (β=4.8×10(-3), p=0.006). CONCLUSIONS: These results strongly support the hypothesis that saturated fatty acids are associated with insulin resistance and glucose intolerance and that saturated fatty acids are significant risk factors for type 2 diabetes.
OBJECTIVES:Type 2 diabetes and the consumption of saturated fatty acids (FAs) are on the rise among Alaska Inuits. This analysis, based on a cross-sectional study, explores the possible associations of saturated FA content in red blood cells (RBCs) and parameters of glucose metabolism in a sample of Alaska Natives. STUDY DESIGN AND METHODS: The sample included 343 women and 282 men aged 35-74. Statistical analyses explored the associations of selected RBC (myristic, palmitic and stearic acids) FAs with fasting glucose (plasma), fasting insulin (plasma), 2h glucose (2-hour glucose tolerance test), 2hinsulin and homeostasis model assessment (HOMA) index. The models included sex and glucose metabolism status as fixed factors and age, body mass index (BMI), waist circumference, physical activity (METS) and FA content in RBCs as covariates. Measures of insulin, glucose and HOMA index were used as dependent variables. RESULTS:Myristic acid was positively associated with fasting insulin (β=0.47, p<0.001), 2hinsulin (β=0.53, p=0.02) and HOMA index (β=0.455, p<0.001). Palmitic acid was associated with 2h glucose (β=2.3×10(-2), p<0.001) and 2hinsulin (β=5.6×10(-2), p=0.002) and stearic acid was associated with fasting glucose (β=4.8×10(-3), p=0.006). CONCLUSIONS: These results strongly support the hypothesis that saturated fatty acids are associated with insulin resistance and glucose intolerance and that saturated fatty acids are significant risk factors for type 2 diabetes.
Authors: Sven O E Ebbesson; Amanda I Adler; Patricia M Risica; Lars O E Ebbesson; Jeun-Liang Yeh; Oskar T Go; William Doolittle; Gary Ehlert; Michael Swenson; David C Robbins Journal: Int J Circumpolar Health Date: 2005-09 Impact factor: 1.228
Authors: B Vessby; M Uusitupa; K Hermansen; G Riccardi; A A Rivellese; L C Tapsell; C Nälsén; L Berglund; A Louheranta; B M Rasmussen; G D Calvert; A Maffetone; E Pedersen; I B Gustafsson; L H Storlien Journal: Diabetologia Date: 2001-03 Impact factor: 10.122
Authors: Sven O E Ebbesson; M Elizabeth Tejero; Elizabeth D Nobmann; Juan Carlos Lopez-Alvarenga; Lars Ebbesson; Terri Romenesko; Elizabeth A Carter; Helaine E Resnick; Richard B Devereux; Jean W MacCluer; Bennett Dyke; Sandra L Laston; Charlotte R Wenger; Richard R Fabsitz; Anthony G Comuzzie; Barbara V Howard Journal: J Cardiometab Syndr Date: 2007
Authors: Daniel A Enquobahrie; Marie Denis; Mahlet G Tadesse; Bizu Gelaye; Habtom W Ressom; Michelle A Williams Journal: J Clin Endocrinol Metab Date: 2015-09-25 Impact factor: 5.958
Authors: Sarah Brice Russo; Catalin F Baicu; An Van Laer; Tuoyu Geng; Harinath Kasiganesan; Michael R Zile; L Ashley Cowart Journal: J Clin Invest Date: 2012-11 Impact factor: 14.808
Authors: Kathryn R Koller; Jesse S Metzger; Stacey E Jolly; Jason G Umans; Scarlett E Hopkins; Cristiane Kaufmann; Amy S Wilson; Sven O E Ebbesson; Terry W Raymer; Melissa A Austin; Barbara V Howard; Bert B Boyer Journal: Diabetes Res Clin Pract Date: 2015-03-11 Impact factor: 5.602
Authors: Baris Akinci; Angela Subauste; Nevin Ajluni; Nazanene H Esfandiari; Rasimcan Meral; Adam H Neidert; Akin Eraslan; Rita Hench; Diana Rus; Barbara McKenna; Hero K Hussain; Thomas L Chenevert; Marwan K Tayeh; Amit R Rupani; Jeffrey W Innis; Christos S Mantzoros; Hari S Conjeevaram; Charles L Burant; Elif A Oral Journal: Med (N Y) Date: 2021-05-12
Authors: Jessica C Ralston; Michael A Zulyniak; Daiva E Nielsen; Shannon Clarke; Alaa Badawi; Ahmed El-Sohemy; David Wl Ma; David M Mutch Journal: Nutr Metab (Lond) Date: 2013-06-17 Impact factor: 4.169